Śniadecki M

ORCID: 0000-0002-9587-0476 · 4 papers in corpus · active 2013-2022
2022
Incorporation of Tumor-Free Distance and Other Alternative Ultrasound Biomarkers into a Myometrial Invasion-Based Model Better Predicts Lymph Node Metastasis in Endometrial Cancer: Evidence and Future Prospects.
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics12112604

Myometrial invasion (MI) is a parameter currently used in transvaginal ultrasound (TVS) in endometrial cancer (EC) to determine local staging; however, without molecular diagnostics, it is insufficient for the selection of high-risk cases, …

2021
Ultrasound Measurement of Tumor-Free Distance from the Serosal Surface as the Alternative to Measuring the Depth of Myometrial Invasion in Predicting Lymph Node Metastases in Endometrial Cancer.
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics11081472

BackgroundUltrasonography's usefulness in endometrial cancer (EC) diagnosis consists in its roles in staging and prediction of metastasis. Ultrasound-measured tumor-free distance from the tumor to the uterine serosa (uTFD) is a promising ma…

2014
Mannose-Binding Lectin (MBL) and MBL-associated serine protease-2 (MASP-2) in women with malignant and benign ovarian tumours.
Cancer immunology, immunotherapy : CII ·doi:10.1007/s00262-014-1579-y

Mannose-Binding Lectin (MBL) is a serum pattern recognition molecule, able to activate complement in association with MASP proteases. Serum levels of MBL and MASP-2, activities of MBL-MASP complexes, single nucleotide polymorphisms of the M…

2013
Ficolin-2 and ficolin-3 in women with malignant and benign ovarian tumours.
Cancer immunology, immunotherapy : CII ·doi:10.1007/s00262-013-1445-3

Ficolins are serum pattern recognition molecules. They have opsonic properties and are able to activate complement via the lectin pathway. This paper reports investigations concerning ficolin-2 and ficolin-3 in ovarian cancer (OC). Their se…